These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 356915)

  • 41. Expression of cryptantigen Th on paroxysmal nocturnal hemoglobinuria erythrocytes in association with a hemolytic exacerbation.
    Nakakuma H; Hidaka M; Nagakura S; Nishimura Y; Iwamoto N; Horikawa K; Kawaguchi T; Kagimoto T; Takatsuki K
    J Clin Invest; 1995 Jul; 96(1):201-6. PubMed ID: 7542278
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Features, reason for testing, and changes with time of 583 paroxysmal nocturnal hemoglobinuria clones from 529 patients: a multicenter Italian study.
    Cannizzo E; Raia M; De Propris MS; Triolo A; Scarpati B; Marfia A; Stacchini A; Buccisano F; Lanza F; Regazzoli A; Michelutti A; Cesaro S; Conte CA; Vanelli L; Tedone E; Omedè P; Ciriello MM; Caporale R; Catinella V; Pantano G; De Rosa C; Lo Pardo C; Poletti G; Ulbar F; Pavanelli MC; Del Pup L; Ottaviano V; Santonocito AM; Bartocci C; Boscaro E; Arras M; Amodeo R; Mestice A; Oliva B; Ferrari L; Statuto T; D'Auria F; Pianezze G; Tanca D; Visconte F; Rubba F; Musto P; Geuna M; Gatti A; Brando B; Del Vecchio L
    Ann Hematol; 2019 May; 98(5):1083-1093. PubMed ID: 30868306
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Paroxysmal nocturnal hemoglobinuria: stem cells and clonality.
    Brodsky RA
    Hematology Am Soc Hematol Educ Program; 2008; ():111-5. PubMed ID: 19074067
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Decreased number of circulating BFU-Es in paroxysmal nocturnal hemoglobinuria.
    Rotoli B; Robledo R; Luzzatto L
    Blood; 1982 Jul; 60(1):157-9. PubMed ID: 7082835
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes. Studies on C9 binding and incorporation into high molecular weight complexes.
    Rosenfeld SI; Jenkins DE; Leddy JP
    J Exp Med; 1986 Oct; 164(4):981-97. PubMed ID: 3760783
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A standardized flow cytometric method for screening paroxysmal nocturnal haemoglobinuria (PNH) measuring CD55 and CD59 expression on erythrocytes and granulocytes.
    Oelschlaegel U; Besson I; Arnoulet C; Sainty D; Nowak R; Naumann R; Bux Y; Ehninger G
    Clin Lab Haematol; 2001 Apr; 23(2):81-90. PubMed ID: 11488846
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficient retrovirus-mediated PIG-A gene transfer and stable restoration of GPI-anchored protein expression in cells with the PNH phenotype.
    Nishimura Ji ; Phillips KL; Ware RE; Hall S; Wilson L; Gentry TL; Howard TA; Murakami Y; Shibano M; Machii T; Gilboa E; Kanakura Y; Takeda J; Kinoshita T; Rosse WF; Smith CA
    Blood; 2001 May; 97(10):3004-10. PubMed ID: 11342424
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The use of monoclonal antibodies and flow cytometry in the diagnosis of paroxysmal nocturnal hemoglobinuria.
    Hall SE; Rosse WF
    Blood; 1996 Jun; 87(12):5332-40. PubMed ID: 8652849
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oxidative status of red blood cells, neutrophils, and platelets in paroxysmal nocturnal hemoglobinuria.
    Amer J; Zelig O; Fibach E
    Exp Hematol; 2008 Apr; 36(4):369-77. PubMed ID: 18261835
    [TBL] [Abstract][Full Text] [Related]  

  • 50. T-lymphocytes escape membrane defect in paroxysmal nocturnal haemoglobinuria.
    Cooper MR; Currie MS; Rustagi PK; Logue GL
    Br J Haematol; 1983 Oct; 55(2):263-71. PubMed ID: 6604541
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Protection of erythrocytes from human complement-mediated lysis by membrane-targeted recombinant soluble CD59: a new approach to PNH therapy.
    Hill A; Ridley SH; Esser D; Oldroyd RG; Cullen MJ; Kareclas P; Gallagher S; Smith GP; Richards SJ; White J; Smith RA; Hillmen P
    Blood; 2006 Mar; 107(5):2131-7. PubMed ID: 16322479
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of High Sensitivity and Conventional Flow Cytometry for Diagnosing Overt Paroxysmal Nocturnal Hemoglobinuria and Detecting Minor Paroxysmal Nocturnal Hemoglobinuria Clones.
    Park SH; Jeong J; Lee SH; Yoo DW; Choi Y; Jo JC; Lim JH
    Ann Lab Med; 2019 Mar; 39(2):150-157. PubMed ID: 30430777
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum-red cell interactions at low ionic strength: erythrocyte complement coating and hemolysis of paroxysmal nocturnal hemoglobinuria cells.
    Jenkins DE; Hartmann RC; Kerns AL
    J Clin Invest; 1967 May; 46(5):753-61. PubMed ID: 6025481
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of the enhanced susceptibility of paroxysmal nocturnal hemoglobinuria erythrocytes to complement-mediated hemolysis initiated by cobra venom factor.
    Parker CJ; Stone OL; Bernshaw NJ
    J Immunol; 1989 Jan; 142(1):208-16. PubMed ID: 2909615
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Paroxysmal nocturnal hemoglobinuria: an historical overview.
    Parker CJ
    Hematology Am Soc Hematol Educ Program; 2008; ():93-103. PubMed ID: 19074065
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Investigation of the survival of paroxysmal nocturnal hemoglobinuria red cells through the immunophenotyping of reticulocytes.
    Navenot JM; Muller JY; Blanchard D
    Transfusion; 1998 Apr; 38(4):337-42. PubMed ID: 9595015
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relations between surface charge and in vitro lysis of red blood cells in paroxysmal nocturnal haemoglobinuria.
    Hause LL; Koethe SM; Rothwell DJ; Straumfjord JV
    Scand J Haematol; 1978 Feb; 20(2):141-6. PubMed ID: 635466
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cytometric analysis of paroxysmal nocturnal hemoglobinuria erythrocytes.
    Bunyaratvej A; Butthep P
    J Med Assoc Thai; 1992 Jan; 75 Suppl 1():237-42. PubMed ID: 1402472
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The complement receptor 2/factor H fusion protein TT30 protects paroxysmal nocturnal hemoglobinuria erythrocytes from complement-mediated hemolysis and C3 fragment.
    Risitano AM; Notaro R; Pascariello C; Sica M; del Vecchio L; Horvath CJ; Fridkis-Hareli M; Selleri C; Lindorfer MA; Taylor RP; Luzzatto L; Holers VM
    Blood; 2012 Jun; 119(26):6307-16. PubMed ID: 22577173
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria.
    Hillmen P; Hall C; Marsh JC; Elebute M; Bombara MP; Petro BE; Cullen MJ; Richards SJ; Rollins SA; Mojcik CF; Rother RP
    N Engl J Med; 2004 Feb; 350(6):552-9. PubMed ID: 14762182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.